Clin2
NCT07396441Possibly a fitRecruiting

Kelulut honey therapy for juvenile glaucoma

Juvenile Open Angle GlaucomaDry Eye Disease (DED)Interleukin 6Retinal Nerve Fiber Layer ThicknessHbA1c Level

Part of Eyes & vision clinical trials.

This trial tests if adding Kelulut honey to standard treatment can help protect the optic nerve in young people with juvenile open-angle glaucoma. It looks at eye pressure, nerve thickness, and dry eye symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
15 years to 40 years
Study type
Interventional

Who can take part

  • Diagnosed with juvenile open-angle glaucoma (JOAG)
  • Between 15 and 40 years old
  • Currently on standard treatment and eye pressure is well-controlled
  • No allergy to honey or honey-based products
  • Not taking other honey, antioxidant, or herbal supplements for the past 3 months
  • No other serious eye or nerve diseases, diabetes, or autoimmune conditions

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07279324Not yet recruiting
Kelulut honey eyedrops for dry eyes

This study tests whether eyedrops made from Kelulut honey, a natural product from stingless bees, are safe and effective for treating symptoms of dry eye disease. If it works, it could offer a new option to help keep your eyes comfortable and protect the surface of your eye.

Kota Bharu, Kelantan
NCT07273747Recruiting
Kelulut honey for eye allergy and dry eye

This study tests if Kelulut honey eye drops can help people with both allergic conjunctivitis (eye allergies) and dry eye symptoms. If you have been diagnosed with eye allergies and still have bothersome symptoms despite treatment, this trial may offer a natural option to explore.

Kota Bharu, Kelantan
NCT07619482Enrolling by invitation· Phase 1/Phase 2
Insulin eye drops for glaucoma

This study tests whether insulin eye drops can help people with glaucoma by protecting the optic nerve. It is an early-stage trial that may offer a new way to manage the condition.

Palo Alto, California
NCT07777861Recruiting· Phase 2
Testing an eye drop for worsening glaucoma

This study tests an eye drop (G01) for people with primary open-angle glaucoma that is getting worse despite current treatments. It aims to see if G01 can safely slow down or stop the progression of glaucoma.

Beijing, Beijing Municipality
NCT07847073Recruiting· Phase 4
Comparing eye drops for glaucoma and their effect on the optic nerve

This trial tests two eye drops—Rhopressa (netarsudil) and timolol—at lowering eye pressure in people with open-angle glaucoma. The study uses a special camera to see if treatment helps protect the nerve cells in the back of the eye.

Bloomington, Indiana
NCT07074782Not yet recruiting
Using eye drops to protect nerve cells in glaucoma

This study looks at whether certain glaucoma eye drops might help protect the nerve cells in your eye over time. If you've been using the same type of eye drop for a few years, researchers will review your past eye tests to see how your vision and eye health have changed.

Bonn

Hear when a new Dry Eye Disease (DED) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.